Literature DB >> 25187570

Imaging and management of greater trochanteric pain syndrome.

Rajat Chowdhury1, Sahar Naaseri2, Justin Lee2, Gajan Rajeswaran2.   

Abstract

Greater trochanteric pain syndrome (GTPS) is a commonly diagnosed regional pain syndrome with a wide spectrum of aetiologies, reflecting the anatomy of the structures outside the hip joint capsule. There are five muscle tendons that insert on to the greater trochanter and three bursae in the region of the greater trochanter. The term GTPS includes tendinopathies, tendinous tears, bursal inflammation and effusion. There are a range of treatments and therapies depending on the specific diagnosis and severity of the condition. Many patients with GTPS can be successfully managed conservatively with weight loss and non-steroidal anti-inflammatory drugs. Patients suffering from more chronic pain can receive varying degrees of symptomatic relief with lateral hip corticosteroid and local anaesthetic injections. More severe refractory cases of GTPS can be treated with surgical intervention. It is therefore important to make the correct diagnosis to ensure that appropriate management can be implemented. The clinical features of GTPS however are often non-specific because common conditions such as lumbar radicular pain and hip joint osteoarthritis can present with an almost identical form of lateral hip pain. The various diagnostic imaging modalities have particular strengths and weaknesses with ultrasound being the best first-line investigation due to its availability, low cost, dynamic nature and ability to guide treatments such as steroid injections. MRI can be very helpful in the further investigation of patients in whom there is diagnostic uncertainty as to the cause of lateral hip pain and in whom specialist orthopaedic referral is being considered. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25187570     DOI: 10.1136/postgradmedj-2013-131828

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  13 in total

1.  Surgery for greater trochanteric pain syndrome after total hip replacement confers a poor outcome.

Authors:  Eve Robertson-Waters; James R Berstock; Michael R Whitehouse; Ashley W Blom
Journal:  Int Orthop       Date:  2017-07-28       Impact factor: 3.075

2.  Greater trochanteric pain syndrome: a review of diagnosis and management in general practice.

Authors:  Christopher Jb Speers; Gurjit S Bhogal
Journal:  Br J Gen Pract       Date:  2017-10       Impact factor: 5.386

3.  Outcomes and cost-effectiveness of ultrasound-guided injection of the trochanteric bursa.

Authors:  William G Mitchell; Sharon C Kettwich; Wilmer L Sibbitt; Randy R Sibbitt; Maheswari Muruganandam; Noelle A Rolle; William A Hayward; Roderick A Fields; Luis P Roldan; N Suzanne Emil; Monthida Fangtham; Arthur D Bankhurst
Journal:  Rheumatol Int       Date:  2018-01-20       Impact factor: 2.631

4.  Endoscopic Trochanteric Bursectomy and Iliotibial Band Release for Persistent Trochanteric Bursitis.

Authors:  Justin J Mitchell; Jorge Chahla; Alexander R Vap; Travis J Menge; Eduardo Soares; Jonathan M Frank; Chase S Dean; Marc J Philippon
Journal:  Arthrosc Tech       Date:  2016-10-17

5.  Endoscopic Treatment of Greater Trochanteric Pain Syndrome - A Case Series of 11 Patients.

Authors:  Peter Joachim Bruun Thomassen; Trude Basso; Olav Andreas Foss
Journal:  J Orthop Case Rep       Date:  2019 Jan-Feb

6.  Treatment of trochanteric bursitis: our experience.

Authors:  Jasmin Nurkovic; Ljubisa Jovasevic; Admira Konicanin; Zoran Bajin; Katarina Parezanovic Ilic; Vesna Grbovic; Aleksandra Jurisic Skevin; Zana Dolicanin
Journal:  J Phys Ther Sci       Date:  2016-07-29

7.  A double blind randomised control trial investigating the efficacy of platelet rich plasma versus placebo for the treatment of greater trochanteric pain syndrome (the HIPPO trial): a protocol for a randomised clinical trial.

Authors:  Eshan Oderuth; Mohammed Ali; Ismael Atchia; Ajay Malviya
Journal:  Trials       Date:  2018-09-21       Impact factor: 2.279

8.  AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study.

Authors:  Roberto Eleopra; Sara Rinaldo; Christian Lettieri; Andrea Santamato; Paolo Bortolotti; Carmelo Lentino; Carmine Tamborino; Araldo Causero; Grazia Devigili
Journal:  Toxins (Basel)       Date:  2018-10-31       Impact factor: 4.546

9.  Long-term outcome of low-energy extracorporeal shockwave therapy on gluteal tendinopathy documented by magnetic resonance imaging.

Authors:  Kyoung-Ho Seo; Joon-Youn Lee; Kyungjae Yoon; Jong Geol Do; Hee-Jin Park; So-Yeon Lee; Young Sook Park; Yong-Taek Lee
Journal:  PLoS One       Date:  2018-07-17       Impact factor: 3.240

10.  High volume image-guided injections and structured rehabilitation improve greater trochanter pain syndrome in the short and medium term: a combined retrospective and prospective case series.

Authors:  Sarah Morton; Otto Chan; Jessica Price; Melanie Pritchard; Tom Crisp; John D Perry; Dylan Morrissey
Journal:  Muscles Ligaments Tendons J       Date:  2015-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.